St. Louis, MO, United States of America

Matthew James Graneto



Average Co-Inventor Count = 7.4

ph-index = 22

Forward Citations = 1,358(Granted Patents)


Inventors with similar research interests:


Location History:

  • Chestefield, MO (US) (2000)
  • St. Louis, MO (US) (1992 - 2006)
  • Chesterfield, MO (US) (2000 - 2012)

Company Filing History:


Years Active: 1992-2012

Loading Chart...
Loading Chart...
69 patents (USPTO):

Title: **Matthew James Graneto: Innovator in Pharmaceutical Inventions**

Introduction

Matthew James Graneto, a prolific inventor based in St. Louis, MO (US), holds an impressive portfolio of 69 patents. His contributions to the field of pharmaceuticals highlight his expertise in developing innovative compounds aimed at addressing various medical conditions. Graneto's work showcases his commitment to enhancing healthcare through scientific advancements.

Latest Patents

Among his notable inventions are two recent patents that demonstrate his focus on combating inflammation and related disorders. The first, titled "Pyrazole derivatives as 5-LO-inhibitors," pertains to compounds characterized by their ability to inhibit 5-lipoxygenase, which is crucial in the inflammatory process. It discusses processes for synthesizing these compounds and their use in pharmaceutical compositions. The second patent, "Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors," targets the development of prodrugs aimed at effectively treating inflammation and inflammation-related disorders, aiding in more targeted therapeutic responses.

Career Highlights

Matthew's career is underscored by his significant contributions to prominent companies such as G.D. Searle & Company and Pharmacia Corporation. His roles in these organizations have allowed him to apply his innovative capabilities passionately and significantly influence the pharmaceutical industry.

Collaborations

Throughout his career, Graneto has collaborated with notable professionals in the field, including John Jeffrey Talley and Stephen R. Bertenshaw. These collaborations have further enriched his work, leading to the advancement of numerous projects and patents.

Conclusion

Matthew James Graneto exemplifies a dedicated inventor, continually pushing the boundaries of pharmaceutical innovation. With a wealth of patents and collaborative experiences, he significantly contributes to the landscape of drug development, providing solutions to complex medical issues. His work undoubtedly enhances the efforts to improve the quality of healthcare through innovative pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…